Concepedia

Bengt J nsson

BJ

4

Publications

248

Citations

4

H-Index

1998

Active since

Affiliations

Stockholm School of Economics(Current)

Bengt J nsson is an author at Stockholm School of Economics specializing in medicine, outcomes research, and public health.

Top concepts

MedicineHealth PolicyPublic HealthHealth EconomicsOutcomes ResearchSurgeryBusinessOncologyEconomicsCardiology

Publications per year

1998–2003

4

Publications

4

Cost Effectiveness of Alendronate (Fosamax??) for the Treatment of Osteoporosis and Prevention of Fractures

Olof Johnell, Bengt J nsson, Linus J nsson et al. · PharmacoEconomics · 2003 · 120 citations

Bone Disease, Bone Health, Health Economics +5

The Economic Cost of Multiple Sclerosis in Sweden in 1994

Freddie Henriksson, Bengt J nsson · PharmacoEconomics · 1998 · 76 citations

Economics, Applied Economics, Health Economics +9

Cost Effectiveness of Bisoprolol in the Treatment of Chronic Congestive Heart Failure in Sweden

Mattias Ekman, Niklas Zethraeus, Bengt J nsson · PharmacoEconomics · 2001 · 36 citations

Heart Failure, Cardiovascular Disease, Health Policy +8

Cost-Effectiveness Analysis of Exemestane Compared with Megestrol in Advanced Breast Cancer

Peter Lindgren, Bengt J nsson, Alberto Redaelli et al. · PharmacoEconomics · 2002 · 16 citations

Advanced Breast Cancer, Breast Oncology, Oncology +8

Rows per page

1–4 of 4